(PharmaNewsWire.Com, February 20, 2022 ) Nerve Repair and Regeneration market size was estimated at $6.35 billion in 2020, growing at a CAGR of 9.45% during the forecast period 2021-2026. Nerve repair and regeneration involve the replacement of nerve tissue, cells, and biological products that have been destroyed as the olfactory epithelium which is constantly regenerating. The brain, spinal cord, and peripheral nerves, which make up the peripheral nervous system, are vulnerable to a variety of injuries ranging from trauma to neurodegenerative disorders such as amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis, Alzheimer's disease, and multiple system atrophy. Peripheral nerves connect the central nervous system, brain, and spinal cord to other body components including muscles and skin. These nerves are delicate and easily injured, making it difficult for the brain to connect with muscles and organs. Nerve injuries are prevalent, and they can be caused by either blunt trauma or traction injuries. The nerve repair and regeneration devices aid in the regeneration of peripheral nerve systems. Increasing incidence of neurologic disorder including Alzheimer’s disease, neuropathy, stroke and others is one of the major factors driving the growth of the market. An increasing number of geriatric population across the globe is set to further enhance the overall market development of the Nerve Repair and Regeneration Market for the period 2021-2026.
Nerve Repair and Regeneration Market Segment Analysis – By Product Type
Based on product type, the market for Nerve Repair and Regeneration is segmented into Biomaterials and Neurostimulation and Neuromodulation Devices. Neurostimulation and Neuromodulation Devices, and Biomaterials held the largest share in the Nerve Repair and Regeneration market in 2020. Electrodes are applied to the brain, spinal cord, or peripheral nerves in neurostimulation devices. They influence every part of the body and treat almost every condition or symptom, including stroke, spinal cord injury, and others. The huge number of commercially available spinal cord devices, as well as their diverse applications. Major players are investing in the development of more productive devices which is expected to expand the Nerve Repair and Regeneration market. However, Biomaterials is estimated to register higher CAGR of 10.62% during the forecast period 2021-2026 owing to its ability to enhance and replace damaged tissue.
Nerve Repair and Regeneration Market Segment Analysis – By Application
On the basis of application, market for Nerve Repair and Regeneration is categorized in Stem Cell Therapy, Nerve Grafting, Neurostimulation and Neuromodulation Applications, and Direct Nerve Repair/Neurorrhaphy. Direct Nerve Repair/Neurorrhaphy held the largest share and also is estimated to register a higher CAGR of 11.24% during the forecast period 2021-2026. Direct Nerve Repair/Neurorrhaphy is the recommended and gold standard approach for the surgical repair of peripheral nerves. The growing incidence of neurological disorders worldwide is increasing Nerve Repair and Regeneration market.
Nerve Repair and Regeneration Market Segment Analysis – By Geography
North America dominated the Nerve Repair and Regeneration market with a major share of 43% in 2020. This is attributed to the presence of large Nerve Repair and Regeneration market players that have technologically improved equipment are readily available in this region. Furthermore, growing initiatives and funding from the government in this region are contributing to the growth of the market in this region.
However, Asia Pacific is estimated to grow at a faster CAGR during the forecast period 2021-2026 owing to rising geriatric population in this region. Increasing healthcare expenditure in this region is also increasing the growth of the market in this region.
Increasing Incidence of Neurological Disorders such as Alzheimer’s Disease, Stroke and Others
The increasing incidence of a neurological disorders such as Alzheimer’s disease, and others across the globe is increasing the growth of the Nerve Repair and Regeneration Market. According to, World Health Organization (WHO), Alzheimer's disease and related dementia affects approximately 50 million people globally, with the number estimated to rise to 152 million by 2050. Additionally, growing healthcare expenditure is also practiced to increase the growth of the Nerve Repair and Regeneration market during the forecast period 2021-2026.
Rising Government Funding for Research and Development of Neurologic Disorder
Increasing government funding for neurologic disorder disease is increasing the growth of the Nerve Repair and Regeneration market. For instance, in 2020, the Australian government is investing $21.8 million in research for treating a range of neurological disorders, including early Alzheimer’s disease, autism, and others. Moreover, rising technological advancements for nerve repair and regeneration are increasing the growth of the Nerve Repair and Regeneration Market during the forecast period 2021-2026.
Nerve Repair and Regeneration Market Challenges
Long Process For Product Approval and Lack of Skilled Professionals
The major factor that is set to impede the growth of the Nerve Repair and Regeneration market is long process for product approval. Another factor which hampers the growth of the market is lack of skilled professionals and lack of knowledge regarding nerve repair and regeneration products and techniques among patients and physicians.
Nerve Repair and Regeneration Market Landscape
Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Nerve Repair and Regeneration Market. In 2020, the Nerve Repair and Regeneration Market share is consolidated by the top ten players present in the market. The Nerve Repair and Regeneration Market, top 10 companies are
1. Abbott Laboratories
2. Boston Scientific Corporation
3. Medtronic, PLC.
4. Collagen Matrix, Inc.
5. BioWave Corporation
6. NeuroSigma
7. NeuroPace, Inc.
8. AxoGen, Inc.
9. LivaNova, PLC.
10. Integra LifeSciences
Development:
In February 2020, LivaNova, US-based medical technology company collaborated with Verily, for assessing the efficacy of Vagus Nerve Stimulation Therapy (VNS Therapy) in the treatment of difficult-to-treat depression (DTD).
Relevant Titles:
A. Cartilage Repair/ Cartilage Regeneration Market
For more Lifesciences and Healthcare Market reports, please click here
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
